CNY256.68
1.05% today
Shanghai, Jun 25, 09:00 am CET
ISIN
CH1391448177
Symbol
688235
Sector
Industry

BeOne Medicines Target price 2025 - Analyst rating & recommendation

BeOne Medicines Classifications & Recommendation:

Buy
97%
Hold
3%

BeOne Medicines Price Target

Target Price CNY199.41
Price CNY256.68
Deviation
Number of Estimates 26
26 Analysts have issued a price target BeOne Medicines 2026 . The average BeOne Medicines target price is CNY199.41. This is lower than the current stock price. The highest price target is
CNY295.00 14.93%
register free of charge
, the lowest is
CNY155.05 39.59%
register free of charge
.
A rating was issued by 30 analysts: 29 Analysts recommend BeOne Medicines to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BeOne Medicines stock has an average upside potential 2026 of . Most analysts recommend the BeOne Medicines stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion CNY 27.21 36.77
56.19% 35.12%
EBITDA Margin -13.43% 5.77%
72.09% 142.95%

32 Analysts have issued a sales forecast BeOne Medicines 2025 . The average BeOne Medicines sales estimate is

CNY36.8b
Unlock
. This is
22.97% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CNY38.7b 29.50%
Unlock
, the lowest is
CNY34.1b 14.20%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 CNY27.2b 56.19%
2025
CNY36.8b 35.12%
Unlock
2026
CNY44.6b 21.40%
Unlock
2027
CNY52.1b 16.64%
Unlock
2028
CNY58.2b 11.74%
Unlock
2029
CNY65.7b 12.88%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share CNY -3.64 0.88
26.46% 124.18%
P/E 289.42

13 Analysts have issued a BeOne Medicines forecast for earnings per share. The average BeOne Medicines EPS is

CNY0.88
Unlock
. This is
137.61% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
CNY2.57 209.83%
Unlock
, the lowest is
CNY-0.15 93.59%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 CNY-3.64 26.46%
2025
CNY0.88 124.18%
Unlock
2026
CNY3.48 295.45%
Unlock
2027
CNY5.90 69.54%
Unlock
2028
CNY7.75 31.36%
Unlock
2029
CNY8.41 8.52%
Unlock

P/E ratio

Current -108.56 304.22%
2025
289.42 366.61%
Unlock
2026
72.98 74.78%
Unlock
2027
43.02 41.05%
Unlock
2028
32.76 23.85%
Unlock
2029
30.21 7.78%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today